Skip to main content

Wiley-VCH Book, NextGene, Velvet, HeliSphere Technology Center, RDT 1000

Premium
Wiley-VCH has published Next Generation Genome Sequencing: Towards Personalized Medicine. The book, which is edited by Michal Janitz, covers commercially available and emerging new sequencing technologies. It costs $200 in the US.
 

 
Applied Biosystems said last week that two software tools, from SoftGenetics and the European Bioinformatics Institute, are now available at the company's SOLiD Software Development Community website.
 
SoftGenetics is providing its NextGene software, which analyzes data from multiple applications generated on next-generation sequencing platforms and enables the assembly, alignment, quality control, and annotation of de novo sequencing data. The EBI has contributed Velvet, a short read de novo assembly tool. In collaboration with EBI, ABI has developed a de novo assembly bioinformatics pipeline that can produce scaffolds up to 50 kilobases long and convert color-space contigs into base-space contigs for easier viewing and analysis.
 

 
Helicos BioSciences has launched the HeliSphere Technology Center, a website on which the company shares datasets and bioinformatics tools. The first sample datasets released include whole genome sequences of the microbes Escherichia coli, Staphylococcus aureus, and Rhodobacter sphaeroides. Each sample dataset, containing between six and 12 million aligned reads, was generated from one channel of a 50-channel run on the HeliScope sequencer. Data from additional sequencing projects will be posted on the site on a regular basis.
 

 
RainDance Technologies has introduced its instrument, RDT 1000, along with an application for targeted genome sequencing. The RDT 1000 generates picoliter-volume PCR reactions in droplets at a rate of 10 million per hour. According to the company, it can amplify hundreds to thousands of genomic loci with high specificity and uniformity.
 
The company plans to launch the instrument and application, which are currently in early-access testing, during the first quarter of 2009.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.